Form D — NLS Pharmaceutics Ltd.
0001213900-25-005558 · filed 2025-01-22
Offering
- Industry
- Pharmaceuticals
- Exemptions
- 06b
- Total offering
- $499,999
- Total sold
- $499,999
- Minimum investment
- $0
- Investors
- —
- Sales commission
- —
- Finders' fees
- —
Issuer
- Name
- NLS Pharmaceutics Ltd.
- CIK
- 1783036
- Entity
- Other
- Jurisdiction
- SWITZERLAND
- Year incorporated
- —
- Address
- THE CIRCLE 6
ZURICH, V8 8058 - Phone
- +41.44.512.2150
Related persons
-
Alexander Zwyer · Executive OfficerZurich, V8
-
Ronald Hafner · DirectorZurich, V8
-
Nicole Fernandez-McGovern · Executive OfficerZurich, V8
-
Florence Allouche Aknin · DirectorZurich, V8
-
Claudio L. A. Bassetti · DirectorZurich, V8
-
Gian-Marco Rinaldi de la Cruz · DirectorZurich, V8
-
Audrey Greenberg · DirectorZurich, V8
-
Olivier Samuel · DirectorZurich, V8
View original on SEC EDGAR.